A detailed history of Verition Fund Management LLC transactions in Pfizer Inc stock. As of the latest transaction made, Verition Fund Management LLC holds 30,500 shares of PFE stock, worth $799,405. This represents 0.01% of its overall portfolio holdings.

Number of Shares
30,500
Previous 134,500 77.32%
Holding current value
$799,405
Previous $3.76 Million 76.56%
% of portfolio
0.01%
Previous 0.02%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$27.7 - $31.39 $1.36 Million - $1.54 Million
49,011 Added 39.23%
173,945 $5.03 Million
Q2 2024

Aug 14, 2024

SELL
$25.26 - $29.6 $15,939 - $18,677
-631 Reduced 0.5%
124,934 $3.5 Million
Q1 2024

May 14, 2024

SELL
$25.89 - $29.73 $563,418 - $646,984
-21,762 Reduced 14.77%
125,565 $3.48 Million
Q4 2023

Feb 14, 2024

BUY
$26.13 - $33.94 $361,090 - $469,016
13,819 Added 10.35%
147,327 $4.24 Million
Q3 2023

Nov 14, 2023

BUY
$32.09 - $37.51 $1.16 Million - $1.35 Million
36,039 Added 36.97%
133,508 $4.43 Million
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $332,845 - $385,094
9,215 Added 10.44%
97,469 $3.58 Million
Q1 2023

May 15, 2023

BUY
$39.39 - $51.28 $578,599 - $753,251
14,689 Added 19.97%
88,254 $3.6 Million
Q4 2022

Feb 14, 2023

SELL
$41.75 - $54.5 $3.34 Million - $4.36 Million
-79,966 Reduced 52.08%
73,565 $3.77 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $4.52 Million - $5.52 Million
103,397 Added 206.24%
153,531 $6.72 Million
Q2 2022

Aug 15, 2022

SELL
$46.53 - $55.17 $48,298 - $57,266
-1,038 Reduced 2.03%
50,134 $2.63 Million
Q1 2022

May 13, 2022

BUY
$45.75 - $56.69 $2.14 Million - $2.65 Million
46,672 Added 1037.16%
51,172 $2.65 Million
Q4 2021

May 03, 2022

SELL
$41.32 - $61.25 $37,518 - $55,615
-908 Reduced 16.79%
4,500 $266,000
Q4 2021

Feb 14, 2022

SELL
$41.32 - $61.25 $678,598 - $1.01 Million
-16,423 Reduced 75.23%
5,408 $319,000
Q3 2021

Nov 15, 2021

BUY
$39.25 - $50.42 $184,121 - $236,520
4,691 Added 27.37%
21,831 $939,000
Q2 2021

Aug 16, 2021

SELL
$35.91 - $40.68 $227,741 - $257,992
-6,342 Reduced 27.01%
17,140 $671,000
Q4 2020

Feb 16, 2021

BUY
$33.47 - $42.56 $375,801 - $477,863
11,228 Added 91.63%
23,482 $864,000
Q3 2020

Nov 16, 2020

SELL
$31.75 - $37.25 $1.94 Million - $2.28 Million
-61,174 Reduced 83.31%
12,254 $450,000
Q2 2020

Aug 14, 2020

BUY
$30.12 - $36.54 $2.21 Million - $2.68 Million
73,428 New
73,428 $2.4 Million
Q1 2020

May 15, 2020

SELL
$27.03 - $38.62 $1.47 Million - $2.1 Million
-54,317 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$32.92 - $37.36 $1.13 Million - $1.29 Million
34,455 Added 173.47%
54,317 $2.13 Million
Q3 2019

Nov 14, 2019

SELL
$32.49 - $42.13 $313,788 - $406,891
-9,658 Reduced 32.72%
19,862 $714,000
Q2 2019

Aug 14, 2019

BUY
$36.98 - $41.52 $1.09 Million - $1.23 Million
29,520 New
29,520 $1.28 Million
Q3 2018

Nov 15, 2018

SELL
$34.47 - $41.81 $927,243 - $1.12 Million
-26,900 Closed
0 $0
Q2 2018

Aug 15, 2018

SELL
$32.98 - $35.16 $62,661 - $66,804
-1,900 Reduced 6.6%
26,900 $976,000
Q1 2018

May 16, 2018

BUY
$31.91 - $37.02 $919,008 - $1.07 Million
28,800 New
28,800 $1.02 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $147B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.